Xiaomo Biotech Limited
PrivateLast Round
Angel
Jan 10, 2025
Total Funding Raised
$2.16M
Company Overview
Xiaomo Biotech Limited is a biotechnology company that develops and manufactures RNA interference (RNAi) products, including siRNA medicine and RNA pesticides, using its proprietary pro-siRNA biomanufacturing technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xiaomo Biotech Limited Comps
Public and private peers based on sector, stage, and business model.
Xiaomo Biotech Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Jan 10, 2025 |
Xiaomo Biotech Limited Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 10, 2025
Raised $1.39M led by Shanghai Science & Technology Venture Capital
Xiaomo Biotech Limited Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xiaomo Biotech Limited's valuation, stock price, and market status.
